Navigation Links
Skin-Destroying Ulcer Appears in NSW as New Treatment Guidelines Emerge

Infectious disease specialists have revealed the skin- and flesh-destroying Bairnsdale ulcer has struck a man in NSW for the first time, as experts publish new recommendations for treating the tropical infection. //

Also known as the Buruli or Daintree ulcer, Bairnsdale ulcers are caused by Mycobacterium ulcerans infection, and result in the destruction of skin, soft tissue, and sometimes bone.

Associate Professor Paul Johnson, Deputy Director of the Infectious Diseases Department of Austin Health, in Melbourne, and colleagues have used the Medical Journal of Australia to caution GPs and other doctors to look out for the infection in NSW.

M. ulcerans infection was first described in Australia in coastal Victoria (Bairnsdale) in 1948 and since then has been found in central coastal Queensland and the Northern Territory.

Now, Assoc Prof Johnson and colleagues have identified the first known case believed to have originated in NSW.

“Australian primary care clinicians need to be aware that Bairnsdale ulcer may occur in NSW, to ensure early diagnosis and treatment to minimise disability,” he said.

The finding came as Australian plastic surgeons, GPs, laboratory scientists, pathologists, infectious disease physicians and public health experts collaborated to set down new consensus recommendations for the treatment and prevention of M. ulcerans infection.

Assoc Prof Johnson said the recommendations state that antibiotics and surgery are recommended for large ulcers, while smaller ulcers with clear margins can be treated with surgery alone.

The reason for outbreaks and mode of transmission are not yet known, but Assoc Prof Johnson said in endemic areas, direct exposure to the environment and to mosquitos are risk factors for contracting the infection.

“Wearing protective clothing and insect repellent appears protective,” he said.

“Future research should focus on what determines why a particular area becomes endemic.”

In the same issue of the MJA, Dr Daniel O’Brien, an infectious disease specialist at Barwon Health in Geelong, and colleagues said that treating the ulcers with surgery alone failed to eradicate the infection for one in four patients.

However after studying the treatment outcomes in a case series of 40 people in south-eastern Australia, they found that treating the initial ulcers with a combination of antibiotics for up to three months, as well as surgery, eradicated the infection in all patients.

“The combination of (the antibiotics) rifampicin and ciprofloxacin seems promising, and has the potential to provide an easily accessible, relatively well tolerated and inexpensive oral antibiotic treatment that can result in a significant reduction in ... morbidity and cost,” Dr O’Brien said.

In a related editorial, World Health Organisation tropical disease control officer Dr Kingsley Asiedu, and London-based infectious disease physician Dr Mark Wansbrough-Jones, said further research is needed into the treatment, diagnosis, and transmission of Buruli ulcer.

The disease is most common in Africa, they said, where patients cannot readily access or afford surgery.

“More work is needed to develop an ideal treatment strategy, in both developing countries and more sophisticated medical settings,” Dr Asiedu said.

SourceAMA
SRM
'"/>




Related medicine news :

1. Ulcer Surgery connected to danger of Pancreatic Cancer
2. Ulcer causing bug found in stored food
3. Drug Effective for Diabetic Foot Ulcers
4. Prevention Of Recurrent Leg Ulcers
5. Diabetic Ulcers A Probable Cause Of Depression
6. Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas
7. Nobel For Ulcer-Defying Aussie Scientists
8. Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis
9. Concerns About Popular Anti-Ulcer Pill Used For Inducing Labor
10. Novel Treatment Method Directed At Ulcer-Causing Bacteria Deemed A Success
11. Stubborn Ulcerative Colitis Responds to Arthritis Drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... Boca Raton, FL (PRWEB) , ... January 21, 2017 , ... ... from Germany, announced it is bringing its product to the United States as part ... perfected over the last 25 years, Alcovit aims to reduce the productions of nasty ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... ... 21, 2017 , ... The Nobel Biocare™ dental implant company ... for its creos™ line of bone regenerative products. Specifically, the Nobel ... utilizes creos™ allo.gain™ bone graft for a variety of bone reconstruction procedures. In ...
(Date:1/20/2017)... ... January 20, 2017 , ... Source Vitál Apothecary, a skin and body ... oils, announced the company had a successful visit to the 2017 ECRM Diet, Vitamin ... companies that work in the nutritional, sports and health industries a chance to meet ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based ... recently attended the January ECRM Trade Show in Hilton Head, SC, benefiting from ... large range of supplements that keep the body functioning at its peak performance ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology: